In addition to the known mechanisms, how the p62 protein supports cancer development in different tissues, the negative regulation of NLRP1 expression by p62 mRNA mediated by miR-34a-5p represents a novel pathway in the development of cSCCs. The gene discussed is NLRP1; the disease is cancer.